Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
XBiotech Inc | XBIT | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
7.85 | 7.6682 | 8.08 | 8.07 |
Recent News
Date | Time | Source | Heading |
---|---|---|---|
08/2/2024 | 04:36 | EDGAR2 | Form SC 13G/A - Statement of acquisition of beneficial.. |
08/2/2024 | 04:01 | EDGAR2 | Form SC 13G/A - Statement of acquisition of beneficial.. |
06/1/2024 | 02:48 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
05/1/2024 | 01:00 | EDGAR2 | Form 8-K - Current report |
05/1/2024 | 01:00 | GLOBE | XBiotech to Begin Constructing New R&D Facility on its.. |
15/11/2023 | 01:00 | GLOBE | Dr. Alan Kivitz to Chair XBiotech’s Natrunix Program in.. |
10/11/2023 | 06:41 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
26/9/2023 | 23:00 | GLOBE | XBiotech Announces Enrollment Completion of Phase I Clinical.. |
30/8/2023 | 23:00 | GLOBE | XBiotech Announces Enrollment Completion of Phase II,.. |
12/8/2023 | 01:18 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
09/8/2023 | 01:47 | GLOBE | XBiotech Announces First Patient Begins Novel Natrunix.. |
22/5/2023 | 23:00 | GLOBE | FDA Authorizes Phase II Study for Natrunix in Rheumatoid.. |
17/5/2023 | 23:00 | GLOBE | XBiotech Commences Tender Offer to Purchase up to.. |